Santini, Fernando C <br/><br/>
Atezolizumab for the treatment of non-small cell lung cancer.  [electronic resource] 

 -  Expert review of clinical pharmacology  Sep 2017 
 - 935-945 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1751-2441 
<br/><br/><label>Standard No.: </label>10.1080/17512433.2017.1356717  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Agents--administration & dosage<br/>B7-H1 Antigen--antagonists & inhibitors<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Humans<br/>Immunohistochemistry<br/>Immunotherapy--methods<br/>Lung Neoplasms--drug therapy<br/>Molecular Targeted Therapy<br/>Neoplasm Staging<br/>Programmed Cell Death 1 Receptor--antagonists & inhibitors